Literature DB >> 17009117

Aspects of digestive tract tumors in Down syndrome: a literature review.

Daniel Satgé1, Annie J Sasco, Michel J J Vekemans, Marie-Laure Portal, Jean-François Fléjou.   

Abstract

The purpose of this study was to describe the digestive neoplasms found in persons with Down syndrome. Due to intellectual disability, persons with Down syndrome do not convey their symptoms and pain, leading to delayed diagnosis and potentially worse outcome. It is thus important to know which organs are at risk for tumors and possible tumor risk factors. In a review of the literature, we found 13 benign tumors and 127 cancers in 1 fetus, 8 children, and 131 adults with Down syndrome. The review suggests a decreased incidence of digestive cancer, however, with a possible increased incidence of neoplasms of the pancreas and gallbladder. The distribution of cancers is distinct from that in the general population and that in persons with other intellectual disabilities who share the same life conditions, suggesting that constitutional protective factors exist. This review may allow a more specific, adapted medical follow-up for persons with Down syndrome and could help to elucidate the oncogenesis of digestive neoplasms.

Entities:  

Mesh:

Year:  2006        PMID: 17009117     DOI: 10.1007/s10620-006-9131-3

Source DB:  PubMed          Journal:  Dig Dis Sci        ISSN: 0163-2116            Impact factor:   3.199


  87 in total

1.  Hydrops foetalis caused by hepatic haemangioma.

Authors:  G Albano; A Pugliese; M Stabile; F Sirimarco; R Arsieri
Journal:  Acta Paediatr       Date:  1998-12       Impact factor: 2.299

Review 2.  Pancreatic carcinoma.

Authors:  S Rosewicz; B Wiedenmann
Journal:  Lancet       Date:  1997-02-15       Impact factor: 79.321

3.  Inhibition of invasion of epithelial cells by Tiam1-Rac signaling.

Authors:  P L Hordijk; J P ten Klooster; R A van der Kammen; F Michiels; L C Oomen; J G Collard
Journal:  Science       Date:  1997-11-21       Impact factor: 47.728

4.  The incidence of cancer in people with intellectual disabilities.

Authors:  Sheena G Sullivan; Rafat Hussain; Timothy Threlfall; Alan H Bittles
Journal:  Cancer Causes Control       Date:  2004-12       Impact factor: 2.506

5.  Frequent loss of copy number on the long arm of chromosome 21 in human esophageal squamous cell carcinoma.

Authors:  T Mayama; S Fukushige; R Shineha; T Nishihira; S Satomi; A Horii
Journal:  Int J Oncol       Date:  2000-08       Impact factor: 5.650

6.  Risks of leukaemia and solid tumours in individuals with Down's syndrome.

Authors:  H Hasle; I H Clemmensen; M Mikkelsen
Journal:  Lancet       Date:  2000-01-15       Impact factor: 79.321

Review 7.  Folate and carcinogenesis: an integrated scheme.

Authors:  S W Choi; J B Mason
Journal:  J Nutr       Date:  2000-02       Impact factor: 4.798

8.  Cancers and immune related diseases associated with Down's syndrome: a record linkage study.

Authors:  M J Goldacre; C J Wotton; V Seagroatt; D Yeates
Journal:  Arch Dis Child       Date:  2004-11       Impact factor: 3.791

Review 9.  Immunological features of Down's syndrome: a review.

Authors:  L Nespoli; G R Burgio; A G Ugazio; R Maccario
Journal:  J Intellect Disabil Res       Date:  1993-12

10.  ANA, a novel member of Tob/BTG1 family, is expressed in the ventricular zone of the developing central nervous system.

Authors:  Y Yoshida; S Matsuda; N Ikematsu; J Kawamura-Tsuzuku; J Inazawa; H Umemori; T Yamamoto
Journal:  Oncogene       Date:  1998-05       Impact factor: 9.867

View more
  2 in total

1.  A rare case report of an adult with down syndrome and gallbladder cancer.

Authors:  Kaouthar Rais; Najoua El Moutaoukil; Oumayma El Eulj; Abdelkrim Zazour; Ghizlane Kharrasse; Imane Kamaoui; Wafaa Khannoussi; My Zahi Ismaili
Journal:  Ann Med Surg (Lond)       Date:  2022-06-20

2.  Transcriptional regulation of miR-196b by ETS2 in gastric cancer cells.

Authors:  Yu-Lun Liao; Ling-Yueh Hu; Kuo-Wang Tsai; Chew-Wun Wu; Wen-Ching Chan; Sung-Chou Li; Chun-Hung Lai; Meng-Ru Ho; Wen-Liang Fang; Kuo-Hung Huang; Wen-Chang Lin
Journal:  Carcinogenesis       Date:  2012-01-31       Impact factor: 4.944

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.